Mircette

Mircette is a combination of female hormones used to prevent ovulation and pregnancy.

Product dosage: 15mcg
Package (num)	Per pill	Price	Buy
56	1.57 $	87.75 $ (0%)	🛒 Add to cart
84	1.28 $	131.62 $ 107.64 $ (18%)	🛒 Add to cart
112	1.13 $	175.50 $ 126.36 $ (28%)	🛒 Add to cart
168	0.98 $	263.25 $ 164.97 $ (37%)	🛒 Add to cart
224	0.91 $ Best per pill	351.00 $ 203.58 $ (42%)	🛒 Add to cart
Synonyms Azurette Caziant Cesia Emoquette Ortho-cept Solia

Mircette is a combination oral contraceptive pill designed to provide effective pregnancy prevention with a low hormonal load. It contains a blend of ethinyl estradiol and desogestrel, offering a balanced approach to cycle regulation and contraceptive reliability. This formulation is engineered to minimize common estrogen-related side effects while maintaining high efficacy, making it a suitable choice for many women seeking a trustworthy birth control method. Healthcare providers often recommend Mircette for its favorable tolerability profile and consistent performance in preventing ovulation.

Features

• Contains 0.15 mg desogestrel and 0.02 mg ethinyl estradiol per active tablet
• 21 active hormone tablets followed by 2 inert tablets and 5 very low-dose estrogen tablets
• Monophasic dosing for consistent hormone delivery throughout the cycle
• Blister pack with day-of-week indicators for improved adherence
• Manufactured under strict pharmaceutical quality standards

Benefits

• Provides highly effective pregnancy prevention when taken correctly
• May result in lighter, more regular menstrual periods
• Often associated with reduced menstrual cramping and discomfort
• Lower estrogen content may decrease the risk of estrogen-related side effects
• The unique dosing regimen helps maintain hormonal stability during the pill-free interval
• Offers non-contraceptive benefits including potential improvement in acne

Common use

Mircette is primarily prescribed for the prevention of pregnancy in women of reproductive age. It may also be used off-label for the management of menstrual-related disorders such as dysmenorrhea or menorrhagia when hormonal regulation is indicated. Some practitioners prescribe it for cycle control in perimenopausal women or for the treatment of mild to moderate hormonal acne.

Dosage and direction

Take one tablet daily at approximately the same time each day, beginning on the first day of menstrual bleeding or as directed by a healthcare provider. The standard regimen involves taking 21 active white tablets followed by 2 green inert tablets, then 5 yellow tablets containing 0.01 mg ethinyl estradiol. A new pack should be started the day after finishing the previous pack, regardless of menstrual flow. For first-time users, additional contraceptive protection is recommended during the first 7 days of use.

Precautions

• Regular blood pressure monitoring is recommended during treatment
• Smoking increases the risk of serious cardiovascular side effects, especially in women over 35
• May affect glucose tolerance; monitor diabetic patients carefully
• Use with caution in women with a history of depression
• Reduced efficacy may occur with gastrointestinal disturbances
• Not protective against sexually transmitted infections

Contraindications

• History of or current thrombophlebitis or thromboembolic disorders
• Known or suspected carcinoma of the breast or estrogen-dependent neoplasia
• Undiagnosed abnormal genital bleeding
• History of or current cerebrovascular or coronary artery disease
• Impaired liver function or liver disease
• Known or suspected pregnancy
• Hypersensitivity to any component of Mircette

Possible side effects

Common side effects may include nausea, headache, breast tenderness, bloating, or mood changes, typically diminishing after the first few cycles. Less frequently reported effects include changes in libido, weight fluctuation, and melasma. Serious but rare adverse reactions include venous thromboembolism, myocardial infarction, stroke, hepatic neoplasia, gallbladder disease, and hypertension. Any unusual symptoms should be reported promptly to a healthcare provider.

Drug interaction

Mircette may interact with various medications including but not limited to:

• Antibiotics (particularly rifampin)
• Anticonvulsants (carbamazepine, phenytoin, topiramate)
• Antifungal agents (griseofulvin)
• HIV protease inhibitors
• St. John’s Wort
• Certain cholesterol-lowering medications

These interactions may decrease contraceptive efficacy or increase side effect risk. Always inform healthcare providers of all medications being taken.

Missed dose

If one active tablet is missed (24-48 hours late), take it as soon as remembered and continue the schedule normally. If two consecutive active tablets are missed in the first two weeks, take two tablets daily for two days then resume regular schedule using additional contraception for seven days. If three or more active tablets are missed, discard the pack and begin a new pack immediately while using backup contraception for seven days. Specific guidance varies based on cycle week; consult prescribing information or a healthcare provider.

Overdose

Serious ill effects from overdose have not been reported. Nausea, vomiting, or withdrawal bleeding may occur. There is no specific antidote; treatment should be symptomatic and supportive. Medical attention should be sought if concerned about symptoms.

Storage

Store at room temperature (20-25°C or 68-77°F) in a dry place protected from light. Keep in the original packaging until time of use. Keep out of reach of children and pets. Do not use if packaging is damaged or tablets appear abnormal.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Individual results may vary. Mircette is available by prescription only and should be used under appropriate medical supervision. Patients should discuss their complete medical history with a healthcare provider before beginning treatment. Regular follow-up appointments are recommended to monitor continued appropriateness of therapy.

Reviews

Clinical studies demonstrate Mircette’s efficacy rates exceeding 99% with perfect use and approximately 91% with typical use. Patient satisfaction surveys indicate high continuation rates due to favorable side effect profiles. Many users report improved cycle regularity and reduced menstrual symptoms. Healthcare providers appreciate its balanced hormonal approach and reliable performance in appropriate patient populations. Long-term safety data supports its use in healthy, non-smoking women throughout their reproductive years.